Pre-IPO Lepu Biopharma - There Are Still Many Uncertainties
This article analyzed Lepu Biopharma in terms of its core product candidates in the pipeline, the challenges, concerns and future outlook for this...
318 Views
CBPO's Vote Gets Up But Dissenters Lurk
Currently trading at a gross/annualsed spread of 1.5%/7.5%. This assumes payment mid-May if assuming the negotiation process drags out to its full...
341 Views
China Biologics (CBPO US): Firm Offer Backed By Prerequisite Votes
Trading at a gross/annualised spread at 4.4%/11.7%. This looks like a pretty clean deal for around four-five months of work.
458 Views
Golden Meditech (801 HK): Prescription Renewal
Back on 13 January 2017, Golden Meditech Holdings Ltd ("GMH", 801 HK) announced an Offer from Kam Yuen, the chairman & controlling shareholder...
478 Views
(Mostly) Asia M&A: November 2019 Roundup
For the month of November, 21 new deals were discussed on Smartkarma with an overall announced deal size of ~US$75bn, helped in large part by...
601 Views